Publications by authors named "Ryan Bear"

Claim this Profile
R
Retrospective analysis of operative time and time to discharge for laparoscopic vs robotic approaches to appendectomy and cholecystectomy.
Ahmad Oussama Rifai, Emily M Rembetski, Larry Collins Stutts, Zachary D Mazurek, Jenifer L Yeh, Ryan A Bear

J Robot Surg· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-Methylselenocysteine.
C P Coyne, Toni Jones, Ryan Bear

J Cancer Ther· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C-)-[anti-EGFR] in Dual-combination with Epirubicin-(C-)-[anti-HER2/] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole.
C P Coyne, Toni Jones, Ryan Bear

J Cancer Res Ther Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C-)-[anti-HER2/] in Combination with Griseofulvin against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3).
C P Coyne, Toni Jones, Ryan Bear

Med Chem (Los Angeles)· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine-(C-)-[anti-HER2/] Anti-Neoplastic Cytotoxicity in Dual Combination with Mebendazole against Chemotherapeutic-Resistant Mammary Adenocarcinoma.
C P Coyne, Toni Jones, Ryan Bear

J Clin Exp Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Alternative Tubulin Inhibitors on the Potency of a Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate: Influence of incorporating an internal/integral disulfide bond structure and Alternative Tubulin/Microtubule Inhibitors on the Cytotoxic Anti-Neoplastic Potency of Epirubicin-(C-amide)-Anti-HER2/neu Synthesized Utilizing a UV-Photoactivated Anthracycline Intermediate.
C P Coyne, Toni Jones, Ryan Bear

Cancer Clin Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of Gemcitabine-(C-)-[anti-HER2/] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary Adenocarcinoma SKBr-3.
Cody P Coyne, Toni Jones, Ryan Bear

J Cancer Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate.
Cody P Coyne, Toni Jones, Ryan Bear

Cancer Biother Radiopharm· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis